A reference to lab values, and to who sets the targetsHow we verifyHidden costsDealsAbout
OptimizeBiomarkers

Sources/Institution or study

Metabolic-syndrome-based cutoff in a general adult population (Gayoso-Diz et al. 2013, EPIRCE)

Named as the source for 1 optimal-range position across 1 biomarker on this site. How we verify ranges.

01

Every position on this site

One row per marker. The comparison column uses the same simple-range parser the rest of the site does, so it is left blank rather than guessed when a range is tiered, sex-split, or in a different unit than the lab interval.

MarkerTheir rangeVs. the lab reference intervalWhere they stated it
HOMA-IR (Insulin Resistance)<2.0not directly comparableCited document ↗The Spanish EPIRCE study put the cutoff at 2.05 when metabolic syndrome components were considered (1.85 in non-diabetic men), against 3.46 from the 90th percentile

1 verified position shown. Every row above either links to the optimal-ranges document named in our biomarker data or passed the expert-range verification described here; unverified or withheld claims never render.

Not medical advice. © 2026 Ocean Path Ventures LLC.

The monthly dispatch

Price changes, new sources, corrected ranges.

Once a month. Every change we made to the site, and why.